Navigation Links
Battling the bedbug epidemic
Date:3/9/2011

Mom's comforting tuck-them-in-words "Sleep tight, don't let the bedbugs bite" is becoming an impossible dream for millions of people as the world experiences a resurgence of an ancient scourge that is fostering human misery, financial burdens and the risk of exposure to potentially toxic materials. That's the message from the cover story of the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

In the article, C&EN News Editor William G. Schulz points out that bedbugs represent a growing epidemic that is difficult to control. The bugs hide in mattresses, box springs, nightstands, and other areas, emerging at night to dine on human blood. Their bites can cause allergic skin reactions, mental anguish, and loss of sleep. Infestations can be a financial burden, with professional extermination sometimes costing thousands of dollars and taking eight weeks or more. Some chemicals that were once effective against the pests, such as DDT, have been banned due to threats to human health and the environment, leaving exterminators with few effective options for controlling the pests, which have developed the ability to shrug-off some pesticides.

But the fight against bedbugs is intensifying. Scientists are looking for new substances to fight bedbugs that are safe and effective. Officials in Ohio "bedbug ground zero' are seeking Federal government permission to resume use of a pesticide called propoxur that can quickly halt infestations. Propoxur was pulled from the market by its manufacturer after EPA raised safety and efficacy concerns. For now, a combination of pesticides and preventive measures, such as regular inspection, laundering, vacuuming, removing clutter, and sealing up cracks in walls and baseboards, are among the best ways to control the bugs, the article notes.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Battling a bat killer
2. Battling harmful algal blooms
3. Brain atrophy responsible for depression in people battling multiple sclerosis
4. Battling cancer with engineering: NCI funds new $13 million cancer research center led by Cornell
5. Battling bacteria in the blood: Researchers tackle deadly infections
6. Super-sized world: Conference addresses global obesity epidemic, explores policies, interventions
7. Global Obesity Summit 2010 in Jackson addresses growing epidemic at ground zero
8. DGAC report offers food and nutrition practitioners insights on helping combat obesity epidemic
9. Obesity, diabetes epidemics continue to grow in California, UCLA study finds
10. Epidemic played large role in shift of attitudes on abortion, author says
11. Researchers embark on work to control the prion epidemic affecting deer in the USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... CA (PRWEB) , ... February 24, 2017 , ... Delpor, ... a $224K grant from the National Institute of Mental Health (NIMH) for the further ... on Delpor’s PROZOR technology and is expected to deliver therapeutic levels of ...
(Date:2/24/2017)... -- Symic Bio, a biopharmaceutical company focused on matrix ... announced today the completion of enrollment for the SHIELD ... trial will evaluate the safety and efficacy of SB-030, ... restenosis following angioplasty. "We,re pleased to ... Nathan Bachtell , M.D., Chief Medical Officer of ...
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
Breaking Biology Technology: